A Case of Psoriasiform Dermatitis Followed by Tumor Necrosis Factor Inhibitor Treated with Phototherapy
Journal of Rheumatic Diseases
;
: 270-274, 2013.
Artículo
en Coreano
| WPRIM
| ID: wpr-171503
ABSTRACT
Although tumor necrosis factor (TNF)-alpha antagonist is a successful treatment modality for various autoimmune diseases, including rheumatoid arthritis (RA), ankylosing spondylitis and psoriatic arthritis, many adverse effects have been reported. Cutaneous adverse reactions of TNF-alpha antagonist include skin rash, urticaria, lupus like rash, seborrheic dermatitis and different kinds of psoriasiform dermatitis. We report a case of psoriasiform dermatitis during TNF-alpha antagonist treatment in a 50-year-old woman with RA. The patient has been treated with adalimumab. After 2 months, she developed pruritic erythematous eruption and desquamative lesions on the head and limbs, which were defined as psoriasiform change by a skin biopsy. These skin lesions are successfully treated with combination therapy, including cessation of adalimumab, corticosteroid and phototherapy.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Fototerapia
/
Artritis Reumatoide
/
Piel
/
Enfermedades Autoinmunes
/
Urticaria
/
Biopsia
/
Factor de Necrosis Tumoral alfa
/
Dermatitis Seborreica
/
Dermatitis
/
Exantema
Límite:
Femenino
/
Humanos
Idioma:
Coreano
Revista:
Journal of Rheumatic Diseases
Año:
2013
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS